Detalles de la búsqueda
1.
Longitudinal molecular trajectories of diffuse glioma in adults.
Nature
; 576(7785): 112-120, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31748746
2.
Patient-Reported Outcomes of Accelerated Aging: A Novel Approach to Investigate Second Cancer Risk in Adolescent and Young Adult (18-39 Years) Cancer Survivors.
Oncologist
; 29(4): e526-e534, 2024 Apr 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37995309
3.
Exploring the interconnectedness between health-related quality of life factors among long-term adolescent and young adult cancer survivors (AYAs): a network analysis.
Support Care Cancer
; 32(2): 104, 2024 Jan 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38217712
4.
Impact of timing of antiseizure medication withdrawal on seizure recurrence in glioma patients: a retrospective observational study.
J Neurooncol
; 164(3): 545-555, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37755633
5.
First-line antiepileptic drug treatment in glioma patients with epilepsy: Levetiracetam vs valproic acid.
Epilepsia
; 62(5): 1119-1129, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33735464
6.
The effectiveness of antiepileptic drug treatment in glioma patients: lamotrigine versus lacosamide.
J Neurooncol
; 154(1): 73-81, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34196916
7.
The TICking clock of EGFR therapy resistance in glioblastoma: Target Independence or target Compensation.
Drug Resist Updat
; 43: 29-37, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31054489
8.
Health-related conditions among long-term cancer survivors diagnosed in adolescence and young adulthood (AYA): results of the SURVAYA study.
J Cancer Surviv
; 2024 May 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38740702
9.
Adherence to the World Cancer Research Fund/American Institute for Cancer Research recommendations for cancer prevention in adolescent and young adult (AYA) cancer survivors: results from the SURVAYA study.
J Cancer Surviv
; 2024 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38224397
10.
Pre-treatment fertility preservation and post-treatment reproduction in long-term survivors of adolescent and young adult (AYA) cancer.
J Cancer Surviv
; 2024 Feb 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38316726
11.
The Epigenetic Evolution of Glioma Is Determined by the IDH1 Mutation Status and Treatment Regimen.
Cancer Res
; 84(5): 741-756, 2024 03 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38117484
12.
Myelotoxicity of Temozolomide Treatment in Patients with Glioblastoma Is It Time for a More Mechanistic Approach?
Cancers (Basel)
; 15(5)2023 Mar 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36900352
13.
Frequency and burden of potentially treatable symptoms in glioma patients with stable disease.
Heliyon
; 9(2): e13278, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36798771
14.
Effectiveness of Antiseizure Medication Triple Therapy in Patients With Glioma With Refractory Epilepsy: An Observational Cohort Study.
Neurology
; 100(14): e1488-e1496, 2023 04 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36754633
15.
Long-term wellbeing and neurocognitive functioning of diffuse low-grade glioma patients and their caregivers: A longitudinal study spanning two decades.
Neuro Oncol
; 25(2): 351-364, 2023 02 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-35908832
16.
The longitudinal relation between executive functioning and multilayer network topology in glioma patients.
Brain Imaging Behav
; 17(4): 425-435, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37067658
17.
Health-related quality of life of Adolescent and Young Adult Cancer Survivors before and during the COVID-19 pandemic: longitudinal improvements on social functioning and fatigue.
J Patient Rep Outcomes
; 7(1): 93, 2023 09 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37702884
18.
Cannabinoids to Improve Health-Related Quality of Life in Patients with Neurological or Oncological Disease: A Meta-Analysis.
Cannabis Cannabinoid Res
; 8(1): 41-55, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35861789
19.
Learning from long-term adolescent and young adult (AYA) cancer survivors regarding their age-specific care needs to improve current AYA care programs.
Cancer Med
; 12(12): 13712-13731, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37119039
20.
Longitudinal characteristics of T2-FLAIR mismatch in IDH-mutant astrocytomas: Relation to grade, histopathology, and overall survival in the GLASS-NL cohort.
Neurooncol Adv
; 5(1): vdad149, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38024241